Connection

Wenjie Tan to Middle East Respiratory Syndrome Coronavirus

This is a "connection" page, showing publications Wenjie Tan has written about Middle East Respiratory Syndrome Coronavirus.
  1. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus. Virol Sin. 2018 Oct; 33(5):453-455.
    View in: PubMed
    Score: 0.160
  2. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient. J Infect Dis. 2018 09 08; 218(8):1249-1260.
    View in: PubMed
    Score: 0.158
  3. A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice. Sci China Life Sci. 2018 Oct; 61(10):1280-1282.
    View in: PubMed
    Score: 0.157
  4. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018 Apr 04; 7(1):60.
    View in: PubMed
    Score: 0.154
  5. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017 May 24; 6(5):e37.
    View in: PubMed
    Score: 0.145
  6. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China. Emerg Microbes Infect. 2016 Nov 09; 5(11):e113.
    View in: PubMed
    Score: 0.139
  7. [Development of Novel Multiplex Real-time RT-PCR Assays for Detection of MERS-CoV Infection]. Bing Du Xue Bao. 2016 05; 32(3):349-54.
    View in: PubMed
    Score: 0.134
  8. [Advances in the Animal Models of MERS-CoV]. Bing Du Xue Bao. 2016 05; 32(3):369-75.
    View in: PubMed
    Score: 0.134
  9. [Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice]. Bing Du Xue Bao. 2016 Jan; 32(1):77-81.
    View in: PubMed
    Score: 0.131
  10. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci Rep. 2015 Dec 03; 5:17554.
    View in: PubMed
    Score: 0.131
  11. Origin and Possible Genetic Recombination of the Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China: Phylogenetics and Coalescence Analysis. mBio. 2015 Sep 08; 6(5):e01280-15.
    View in: PubMed
    Score: 0.129
  12. Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge. EBioMedicine. 2015 Oct; 2(10):1438-46.
    View in: PubMed
    Score: 0.128
  13. [Sequencing and Phylogenetic Analyses of Structural and Accessory Proteins of Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China, 2015]. Bing Du Xue Bao. 2015 Jul; 31(4):333-40.
    View in: PubMed
    Score: 0.127
  14. [Advances in the researches of genomic characterization and molecular detection of Middel East respiratory syndrome coronavirus]. Zhonghua Yu Fang Yi Xue Za Zhi. 2015 May; 49(5):461-4.
    View in: PubMed
    Score: 0.125
  15. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology. 2015 Aug; 145(4):476-84.
    View in: PubMed
    Score: 0.125
  16. The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. Viral Immunol. 2014 Dec; 27(10):543-50.
    View in: PubMed
    Score: 0.122
  17. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen. PLoS One. 2014; 9(11):e112602.
    View in: PubMed
    Score: 0.122
  18. T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. Lancet Infect Dis. 2021 03; 21(3):385-395.
    View in: PubMed
    Score: 0.046
  19. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Nat Commun. 2019 07 11; 10(1):3068.
    View in: PubMed
    Score: 0.042
  20. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. J Virol. 2019 06 15; 93(12).
    View in: PubMed
    Score: 0.042
  21. Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC. J Immunol. 2017 01 15; 198(2):873-882.
    View in: PubMed
    Score: 0.035
  22. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. Antiviral Res. 2017 01; 137:82-92.
    View in: PubMed
    Score: 0.035
  23. Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses. Virol Sin. 2016 Feb; 31(1):85-8.
    View in: PubMed
    Score: 0.033
  24. Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus. PLoS One. 2015; 10(12):e0145561.
    View in: PubMed
    Score: 0.033
  25. [Clinical and Biological Character in Mouse Models for Middle East Respiratory Syndrome Generated by Transduction with Different Doses of DPP4 Molecule]. Bing Du Xue Bao. 2015 Nov; 31(6):593-600.
    View in: PubMed
    Score: 0.032
  26. [Detection of Middle East Respiratory Syndrome Coronavirus by Reverse-transcription Loop-Mediated Isothermal Amplification]. Bing Du Xue Bao. 2015 May; 31(3):269-75.
    View in: PubMed
    Score: 0.031
  27. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe. 2020 03 11; 27(3):325-328.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.